{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:51:32Z","timestamp":1783597892589,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1038\/s41401-020-00605-0","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T12:06:17Z","timestamp":1611576377000},"page":"1556-1566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP\/p97-LC3-mHTT complex"],"prefix":"10.1038","volume":"42","author":[{"given":"Xiao-jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-fu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-ke","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-xiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng-xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-xun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-jun","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"605_CR1","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature05291","volume":"443","author":"DC Rubinsztein","year":"2006","unstructured":"Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006;443:780\u20136.","journal-title":"Nature"},{"key":"605_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.410390411","volume":"39","author":"A D\u00fcrr","year":"1996","unstructured":"D\u00fcrr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, et al. Spinocerebellar ataxia 3 and machado-joseph disease: clinical, molecular, and neuropathoiogicai features. Ann Neurol. 1996;39:490\u20139.","journal-title":"Ann Neurol"},{"key":"605_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","volume":"118","author":"C Duyckaerts","year":"2009","unstructured":"Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009;118:5\u201336.","journal-title":"Acta Neuropathol"},{"key":"605_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai A, Masliah E, Yoshimoto M. The precursor protein of non-Ap component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995;14:467\u201375.","journal-title":"Neuron"},{"key":"605_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","volume":"198","author":"LA Raymond","year":"2011","unstructured":"Raymond LA, Andr\u00e9 VM, Cepeda C, Gladding CM, Milnerwood AJ, Levine MS. Pathophysiology of Huntington\u2019s disease: time-dependent alterations in synaptic and receptor function. Neuroscience. 2011;198:252\u201373.","journal-title":"Neuroscience"},{"key":"605_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"C Soto","year":"2003","unstructured":"Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 2003;4:49\u201360.","journal-title":"Nat Rev Neurosci"},{"key":"605_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tips.2013.12.001","volume":"35","author":"S Yu","year":"2014","unstructured":"Yu S, Liang Y, Palacino J, Difiglia M, Lu B. Drugging unconventional targets: insights from Huntington\u2019s disease. Trends Pharmacol Sci. 2014;35:53\u201362.","journal-title":"Trends Pharmacol Sci"},{"key":"605_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nchembio.1308","volume":"9","author":"AS Tsvetkov","year":"2013","unstructured":"Tsvetkov AS, Arrasate M, Barmada S, Ando DM, Sharma P, Shaby BA, et al. Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. Nat Chem Biol. 2013;9:586\u201392.","journal-title":"Nat Chem Biol"},{"key":"605_CR9","doi-asserted-by":"crossref","unstructured":"A Kakizuka, VCP, a major ATPase in the cells, as a novel target for currently incurable disorders. Innovative Medicine: Basic Research and Development. Tokyo: Springer; (2015).","DOI":"10.1007\/978-4-431-55651-0_5"},{"key":"605_CR10","first-page":"3877","volume":"127","author":"H Meyer","year":"2014","unstructured":"Meyer H, Weihl CC. The VCP\/p97 system at a glance: connecting cellular function to disease pathogenesis. J Cell Sci. 2014;127:3877\u201383.","journal-title":"J Cell Sci"},{"key":"605_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jsb.2012.03.003","volume":"179","author":"M Bug","year":"2012","unstructured":"Bug M, Meyer H. Expanding into new markets-VCP\/p97 in endocytosis and autophagy. J Struct Biol. 2012;179:78\u201382.","journal-title":"J Struct Biol"},{"key":"605_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4161\/auto.6.2.11014","volume":"6","author":"E Tresse","year":"2010","unstructured":"Tresse E, Salomons FA, Vesa J, Bott LC, Kimonis V, Yao TP, et al. VCP\/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy. 2010;6:217\u201327.","journal-title":"Autophagy"},{"key":"605_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molcel.2017.10.028","volume":"69","author":"BJ Van den","year":"2018","unstructured":"Van den BJ, Meyer H. VCP\/p97-mediated unfolding as a principle in protein homeostasis and signaling. Mol Cell. 2018;69:182\u201394.","journal-title":"Mol Cell"},{"key":"605_CR14","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/sj.cdd.4400907","volume":"8","author":"M Hirabayashi","year":"2001","unstructured":"Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y, Kamei Y, et al. VCP\/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ. 2001;8:977\u2013984.","journal-title":"Cell Death Differ"},{"key":"605_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2828","volume":"4","author":"K Fujita","year":"2013","unstructured":"Fujita K, et al. A functional deficiency of TERA\/VCP\/p97 contributes to impaired DNA damage repair in multiple polyglutamine diseases. Nat Commun. 2013;4:1816.","journal-title":"Nat Commun"},{"key":"605_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep06410","volume":"4","author":"H Yang","year":"2014","unstructured":"Yang H, Li JJ, Liu S, Zhao J, Jiang YJ, Song AX, et al. Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology. Sci Rep. 2014;4:6410.","journal-title":"Sci Rep"},{"key":"605_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176:11\u201342.","journal-title":"Cell"},{"key":"605_CR18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","volume":"93","author":"FM Menzies","year":"2017","unstructured":"Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A, et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron. 2017;93:1015\u201334.","journal-title":"Neuron"},{"key":"605_CR19","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1111\/j.1742-4658.2008.06562.x","volume":"275","author":"S Sarkar","year":"2008","unstructured":"Sarkar S, Rubinsztein DC. Huntington\u2019s disease: degradation of mutant huntingtin by autophagy. FEBS J. 2008;275:4263\u201370.","journal-title":"FEBS J"},{"key":"605_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrd3802","volume":"11","author":"DC Rubinsztein","year":"2012","unstructured":"Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov. 2012;11:709\u201330.","journal-title":"Nat Rev Drug Discov"},{"key":"605_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pneurobio.2011.08.013","volume":"97","author":"M Jimenez-Sanchez","year":"2012","unstructured":"Jimenez-Sanchez M, Thomson F, Zavodszky E, Rubinsztein DC. Autophagy and polyglutamine diseases. Prog Neurobiol. 2012;97:67\u201382.","journal-title":"Prog Neurobiol"},{"key":"605_CR22","doi-asserted-by":"publisher","first-page":"29278","DOI":"10.1074\/jbc.M303800200","volume":"278","author":"H He","year":"2003","unstructured":"He H, Dang Y, Dai F, Guo Z, Wu J, She X, et al. Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. J Biol Chem. 2003;278:29278\u201387.","journal-title":"J Biol Chem"},{"key":"605_CR23","doi-asserted-by":"publisher","first-page":"24131","DOI":"10.1074\/jbc.M702824200","volume":"282","author":"S Pankiv","year":"2007","unstructured":"Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, et al. p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282:24131\u201345.","journal-title":"J Biol Chem"},{"key":"605_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nn.2575","volume":"13","author":"E Wong","year":"2010","unstructured":"Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci. 2010;13:805\u201311.","journal-title":"Nat Neurosci"},{"key":"605_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200507002","volume":"171","author":"G Bj\u00f8rk\u00f8y","year":"2005","unstructured":"Bj\u00f8rk\u00f8y G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, et al. p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol. 2005;171:603\u201314.","journal-title":"J Cell Biol"},{"key":"605_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12646","volume":"7","author":"X Guo","year":"2016","unstructured":"Guo X, Sun X, Hu D, Wang YJ, Fujioka H, Vyas R, et al. VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington\u2019s disease. Nat Commun. 2016;7:12646.","journal-title":"Nat Commun"},{"key":"605_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s10637-019-00797-1","volume":"37","author":"H Xie","year":"2019","unstructured":"Xie H, Yin J, Shah MH, Menefee ME, Bible KC, Reidy-Lagunes D, et al. A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma. Invest New Drugs. 2019;37:755\u201362.","journal-title":"Invest New Drugs"},{"key":"605_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nchembio.1313","volume":"9","author":"P Magnaghi","year":"2013","unstructured":"Magnaghi P, D\u2019Alessio R, Valsasina B, Avanzi N, Rizzi S, Asa D, et al. Covalent and allosteric inhibitors of the ATPase VCP\/p97 induce cancer cell death. Nat Chem Biol. 2013;9:548\u201356.","journal-title":"Nat Chem Biol"},{"key":"605_CR29","doi-asserted-by":"crossref","unstructured":"Y Yao, X Cui, I Al-Ramahi, X Sun, B Li, J Hou, et al. A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity. Elife.\u00a02015;4:e05449.","DOI":"10.7554\/eLife.05449"},{"key":"605_CR30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.chembiol.2011.12.020","volume":"19","author":"B Baldo","year":"2012","unstructured":"Baldo B, Paganetti P, Grueninger S. TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in Huntington\u2019s Disease. Chem Biol. 2012;19:264\u201375.","journal-title":"Chem Biol"},{"key":"605_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.neuro.2011.01.002","volume":"3","author":"GF Kwakye","year":"2011","unstructured":"Kwakye GF, Li D, Bowman AB. Novel high-throughput assay to assess cellular manganese levels in a striatal cell line model of Huntington\u2019s disease confirms a deficit in manganese accumulation. Neurotoxicology. 2011;3:630\u20139.","journal-title":"Neurotoxicology"},{"key":"605_CR32","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/j.bbadis.2015.06.010","volume":"1852","author":"B Almeida","year":"2015","unstructured":"Almeida B, Abreu IA, Matos CA, Fraga JS, Fernandes S, Macedo MG, et al. SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97. Biochim Biophys Acta 2015;1852:1950\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"605_CR33","doi-asserted-by":"publisher","first-page":"26714","DOI":"10.1074\/jbc.M601603200","volume":"281","author":"I Al-Ramahi","year":"2006","unstructured":"Al-Ramahi I, Lam YC, Chen HK, de Gouyon B, Zhang M, P\u00e9rez AM, et al. CHIP protects from the neurotoxicity of expanded and wild-type Ataxin-1 and promotes their ubiquitination and degradation. J Biol Chem. 2006;281:26714\u201324.","journal-title":"J Biol Chem"},{"key":"605_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","volume":"66","author":"J Liu","year":"1991","unstructured":"Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991;66:807\u201315.","journal-title":"Cell"},{"key":"605_CR35","doi-asserted-by":"publisher","first-page":"12037","DOI":"10.1073\/pnas.192206699","volume":"99","author":"Q Huai","year":"2002","unstructured":"Huai Q, Kim HY, Liu Y, Zhao Y, Mondragon A, Liu JO, et al. Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc Natl Acad Sci USA. 2002;99:12037\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"605_CR36","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3390\/molecules20023027","volume":"20","author":"E Chapman","year":"2015","unstructured":"Chapman E, Maksim N, de la Cruz F, La JJ. Clai, inhibitors of the AAA+ chaperon p97. Molecules. 2015;20:3027\u201349.","journal-title":"Molecules"},{"key":"605_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/ncb2407","volume":"1","author":"H Meyer","year":"2012","unstructured":"Meyer H, Bug M, Bremer S. Emerging functions of the VCP\/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol. 2012;1:117\u201323.","journal-title":"Nat Cell Biol"},{"key":"605_CR38","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1096\/fj.12-219220","volume":"27","author":"B Lu","year":"2013","unstructured":"Lu B, Palacino J. A novel human embryonic stem cell-derived Huntington\u2019s disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. FASEB J. 2013;27:1820\u20139.","journal-title":"FASEB J"},{"key":"605_CR39","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, et al. Targeting huntingtin expression in patients with Huntington\u2019s disease. N Engl J Med. 2019;380:2307\u201316.","journal-title":"N Engl J Med"},{"key":"605_CR40","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/neuonc\/nox243","volume":"20","author":"J Park","year":"2018","unstructured":"Park J, Shim JK, Kang JH, Choi J, Chang JH, Kim SY, et al. Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres. Neuro Oncol. 2018;20:954\u201365.","journal-title":"Neuro Oncol"},{"key":"605_CR41","doi-asserted-by":"crossref","unstructured":"Li J, Wang C, Wang Z, Zhu C, Li J, Sha T, et al. Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds. Nature. 2019;575:203\u20139.","DOI":"10.1038\/s41586-019-1722-1"},{"key":"605_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ab.2007.08.020","volume":"372","author":"L Chang","year":"2008","unstructured":"Chang L, Bertelsen EB, Wis\u00e9n S, Larsen EM, Zuiderweg ER, Gestwicki JE. High-throughput screen for small molecules that modulate the ATPase activity of the molecular chaperone DnaK. Anal Biochem. 2008;372:167\u201376.","journal-title":"Anal Biochem"},{"key":"605_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ab.2009.08.001","volume":"395","author":"A Weiss","year":"2009","unstructured":"Weiss A, Abramowski D, Bibel M, Bodner R, Chopra V, DiFiglia M, et al. Single-step detection of mutant huntingtin in animal and human tissues:A bioassay for Huntington\u2019s disease. Anal Biochem. 2009;395:8\u201315.","journal-title":"Anal Biochem"},{"key":"605_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1326-7-12","volume":"7","author":"MA Hickey","year":"2012","unstructured":"Hickey MA, Zhu C, Medvedeva V, Lerner RP, Patassini S, Franich NR, et al. Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington\u2019s disease. Mol Neurodegener. 2012;7:12.","journal-title":"Mol Neurodegener"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00605-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00605-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00605-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T11:41:28Z","timestamp":1634038888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-020-00605-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1038\/s41401-020-00605-0","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}